NewHydrogen (NEWH) 10-K 21 Mar 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2018	Mar. 15, 2019	Jun. 30, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	BioSolar Inc
Entity Central Index Key	0001371128
Trading Symbol	BSRC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Ex Transition Period	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Public Float			$ 5,123,735
Entity Common Stock, Shares Outstanding		71,614,917

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
CURRENT ASSETS
Cash	$ 82,697	$ 119,446
Prepaid expenses	23,107	21,644
TOTAL CURRENT ASSETS	105,804	141,090
PROPERTY AND EQUIPMENT
Machinery and equipment	37,225	31,455
Less accumulated depreciation	(26,814)	(23,733)
NET PROPERTY AND EQUIPMENT	10,411	7,722
OTHER ASSETS
Patents, net of amortization of $9,067 and $6,045, respectively	36,269	69,442
Deposit	770	770
TOTAL OTHER ASSETS	37,039	70,212
TOTAL ASSETS	153,254	219,024
CURRENT LIABILITIES
Accounts payable	896	31,845
Accrued expenses	641,366	414,702
Derivative liability	14,032,942	5,239,073
Convertible promissory notes net of debt discount of $265,873 and $5,340, respectively	493,287	396,660
TOTAL CURRENT LIABILITIES	15,168,491	6,082,280
LONG TERM LIABILITIES
Convertible promissory notes net of debt discount of $27 and $351, respectively	1,984,973	1,791,279
TOTAL LONG TERM LIABILITIES	1,984,973	1,791,279
TOTAL LIABILITIES	17,153,464	7,873,559
COMMITMENT AND CONTINGENCIES (SEE NOTE 7)
SHAREHOLDERS' DEFICIT
Preferred stock, $0.0001 par value; 10,000,000 authorized shares, none issued and outstanding
Common stock, $0.0001 par value; 500,000,000 authorized shares 60,639,308 and 41,485,051 shares issued and outstanding, respectively	6,064	4,149
Additional paid in capital	11,646,932	11,127,693
Accumulated deficit	(28,653,206)	(18,786,377)
TOTAL SHAREHOLDERS' DEFICIT	(17,000,210)	(7,654,535)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 153,254	$ 219,024

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Patents, net of amortization	$ 9,067	$ 6,045
Convertible promissory notes net of debt discount, current	265,873	5,340
Convertible promissory notes net of debt discount, non current	$ 27	$ 351
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	60,639,308	41,485,051
Common stock, shares outstanding	60,639,308	41,485,051

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
REVENUE
OPERATING EXPENSES
General and administrative expenses	423,642	1,663,058
Research and development	239,607	176,306
Depreciation and amortization	6,103	9,368
Loss on abandonment of patents	30,151
TOTAL OPERATING EXPENSES	699,503	1,848,732
LOSS FROM OPERATIONS BEFORE OTHER INCOME (EXPENSES)	(699,503)	(1,848,732)
OTHER INCOME/(EXPENSES)
Interest income	25	39
Loss on conversion of debt	(385,531)	(408,144)
Loss on change in derivative liability	(8,391,061)	(178,337)
Interest expense	(390,759)	(349,850)
TOTAL OTHER INCOME (EXPENSES)	(9,167,326)	(936,292)
NET LOSS	$ (9,866,829)	$ (2,785,024)
BASIC AND DILUTED LOSS PER SHARE	$ (0.18)	$ (0.08)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED	53,667,779	35,784,211

Statement of Shareholders' Defi

Statement of Shareholders' Deficit - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2016		$ 2,952	$ 9,354,201	$ (16,001,353)	$ (6,644,200)
Beginning balance, shares at Dec. 31, 2016		29,519,405
Issuance of common shares for converted promissory notes and accrued interest		$ 1,197	508,256		509,453
Issuance of common shares for converted promissory notes and accrued interest, shares		11,965,646
Stock based compensation			1,265,236		1,265,236
Net Loss				(2,785,024)	(2,785,024)
Ending balance at Dec. 31, 2017		$ 4,149	11,127,693	(18,786,377)	(7,654,535)
Ending balance, shares at Dec. 31, 2017		41,485,051
Issuance of common shares for converted promissory notes and accrued interest		$ 1,915	519,239		521,154
Issuance of common shares for converted promissory notes and accrued interest, shares		19,154,257
Net Loss				(9,866,829)	(9,866,829)
Ending balance at Dec. 31, 2018		$ 6,064	$ 11,646,932	$ (28,653,206)	$ (17,000,210)
Ending balance, shares at Dec. 31, 2018		60,639,308

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (9,866,829)	$ (2,785,024)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization expense	6,103	9,368
Stock based compensation		1,265,236
Loss on net change in derivative liability	8,391,061	178,337
Loss on conversion of debt	385,531	408,144
Amortization of debt discount recognized as interest expense	142,598	146,279
Loss on abandonment of patents	30,151
(Increase) Decrease in Changes in Assets
Prepaid expenses	(1,464)	621
Increase (Decrease) in Changes in Liabilities
Accounts payable	(30,949)	15,087
Accrued expenses	312,819	201,469
NET CASH (USED) IN OPERATING ACTIVITIES	(630,979)	(560,483)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(5,770)
Patent expenditures		(700)
NET CASH (USED IN) INVESTING ACTIVITIES	(5,770)	(700)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible promissory notes	600,000	472,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	600,000	472,000
NET DECREASE IN CASH	(36,749)	(89,183)
CASH, BEGINNING OF YEAR	119,446	208,629
CASH, END OF YEAR	82,697	119,446
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	2,262	1,974
Taxes paid
SUPPLEMENTAL SCHEDULE OF NON-CASH TRANSACTIONS
Common stock issued for convertible notes and accrued interest	$ 521,154	$ 509,453

Organization and Line of Busine

Organization and Line of Business	12 Months Ended
	Dec. 31, 2018
Organization and Line of Business [Abstract]
ORGANIZATION AND LINE OF BUSINESS	1. ORGANIZATION AND LINE OF BUSINESS Organization BioSolar, Inc. (the "Company") was incorporated in the state of Nevada on April 24, 2006.  The Company, based in Santa Clarita, California, began operations on April 25, 2006 to develop and market Photovoltaic solar technology products.    Line of Business We are engaged in the development of innovative technologies and materials that will reduce the cost per watt of storing electrical energy. We previously developed BioBacksheet R Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business.  The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. During the year ended December 31, 2018, the Company did not generate any revenue, incurred a net loss of $9,866,829 and used cash in operations of $630,979.  As of December 31, 2018, the Company had a working capital deficiency of $15,062,687 and a shareholders' deficit of $17,000,210.   These factors, among others raise substantial doubt about the Company's ability to continue as a going concern.  Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2018 expressed substantial doubt about our ability to continue as a going concern.   The accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.   The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash infusions. During the year ended December 31, 2018, the Company obtained funds from the issuance of convertible note agreements. Management believes this funding will continue from its' current investors and from new investors. Management believes the existing shareholders, and the prospective new investors will provide the additional cash needed to meet the Company's obligations as they become due and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stock holders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of the Company is presented to assist in understanding the Company's financial statements. The financial statements and notes are representations of the Company's management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Revenue Recognition The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, the Company has not had significant revenues and is in the development stage. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Use of Estimates In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates. Intangible Assets The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. During the years ended December 31, 2018 and 2017 the Company reviewed the capitalized patents for impairment in accordance with ASC 350, and determined there was no impairment. Intangible assets that have finite useful lives continue to be amortized over their useful lives Useful Lives 2018 2017 Patents $ 75,487 $ 75,487 Write-off of abandoned patents (30,151 ) - Less accumulated amortization 15 years (9,067 ) (6,045 ) $ 36,269 $ 69,442 The Company recognized amortization expense of $3,022 and $6,045 for the years ended December 31, 2018 and 2017. Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives: Computer equipment 5 Years Machinery and equipment 10 Years Depreciation expense for the years ended December 31, 2018 and 2017 was $3,080 and $3,323, respectively. Stock-Based Compensation The Company measures the cost of employee services received in exchange for an equity award based on the grant-date fair value of the award. All grants under our stock-based compensation programs are accounted for at fair value and that cost is recognized over the period during which an employee, consultant, or director are required to provide service in exchange for the award (the vesting period). Compensation expense for options granted to employees and non-employees is determined in accordance with the standard as the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measured. Compensation expense for awards granted is re-measured each period. Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility. The Company used Black Scholes to value its stock option awards which incorporated the Company's stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life. The stock options terminate seven (7) years from the date of grant or upon termination of employment. As of December 31, 2018, 15,950,000 stock options are outstanding. Income Taxes Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. On December 22, 2017, the Tax Cut and Jobs Act (the "Tax Act") was signed into law by the President of the United States. The TCJA is a tax reform act that among other things, reduced corporate income tax rate to 21%, effective January 1, 2018. Accordingly, t Research and Development Research and development costs are expensed as incurred. Total research and development costs were $239,607 and $176,306 for the years ended December 31, 2018 and 2017, respectively. Net Earnings (Loss) per Share Calculations Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock based awards (Note 4), plus the assumed conversion of convertible debt (Note 5).     For the year ended December 31, 2018, the Company's diluted loss per share is the same as the basic loss per share, and the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company has excluded 15,950,000 stock options and the shares issuable from convertible debt of $2,744,160, because their impact was anti-dilutive. For the year ended December 31, 2017, the Company's diluted loss per share is the same as the basic loss per share, and the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company excluded 15,975,000 stock options, and the shares issuable from the convertible debt of $2,193,630, because their impact was antidilutive.  For the Years Ended December 31, 2018 2017 Income (Loss) to common shareholders (Numerator) $ (9,866,829 ) $ (2,785,024 ) Basic weighted average number of common shares outstanding (Denominator) 53,667,779 35,784,211 Diluted weighted average number of common shares outstanding (Denominator) 53,667,779 35,784,211 Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2018 and 2017, the amounts reported for cash, inventory, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: · Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; · Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and · Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2018 and 2017: Total (Level 1) (Level 2) (Level 3) Derivative Liability Total Liabilities measured at fair value as of December 31, 2018 $ 14,032,942 $ - $ - $ 14,032,942 Total Liabilities measured at fair value as of December 31, 2017 $ 5,239,073 $ - $ - $ 5,239,073 Fair Value of Financial Instruments The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: Balance as of December 31, 2016 $ 5,044,897 Fair value of derivative liabilities issued 15,840 Gain on change in derivative liability 178,336 Balance as of December 31, 2017 $ 5,239,073 Fair value of derivative liabilities issued 402,808 Loss on change in derivative liability 8,391,061 Balance as of December 31, 2018 $ 14,032,942 Recently Issued Accounting Pronouncements In August 2017, FASB issued accounting standards update ASU-2017-12, "D" (Topic 815) – "Targeted Improvements to Accounting for Hedging Activities", to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company is currently evaluating the impact of the adoption of ASU 2017-12 on the Company's financial statements. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – "Shared-Based Payment Arrangements with Nonemployees", which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company is currently evaluating the impact of the adoption of ASU 2018-07 on the Company's financial statements. In August 2018, the FASB issued to accounting standards update ASU 2018-13, (Topic 820) - "Fair Value Measurement", which changes the unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance. The Company is currently evaluation the impact of the adoption of ASU 2018-13, on the Company's financial statements. Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements. Reclassification Certain amounts in the 2017 financial statements have been reclassified to conform to the presentation used in the 2018 financial statements. There was no material impact on any of the Company's previously issued financial statements.

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK During the year ended December 31, 2018, the Company issued 19,154,257 shares of common stock upon conversion of convertible promissory notes in the amount of $99,470, plus accrued interest of $36,153, with an aggregate fair value loss of $385,531 at prices ranging from $0.0157 - $0.048. During the year ended December 31, 2017, the Company issued 11,965,646 shares of common stock upon conversion of convertible promissory notes in the amount of $78,370, plus accrued interest of $22,939, with an aggregate fair value loss of $408,144 at prices ranging from $0.0350 and $0.0549 per share upon conversion

Stock Options

Stock Options	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK OPTIONS	4. STOCK OPTIONS Stock Options The Company did not grant any stock options during the years ended December 31, 2018 and 2017, respectively. 12/31/2018 12/31/2017 Number of Weighted Number of Weighted Outstanding as of the beginning of the years 15,975,000 $ 0.23 15,975,000 $ 0.23 Granted - - - - Exercised - - - - Expired (25,000 ) $ 0.40 - - Outstanding as of the end of the years 15,950,000 $ 0.23 15,975,000 $ 0.23 Exercisable as of the end of the years 15,950,000 $ 0.23 15,435,000 $ 0.23 The weighted average remaining contractual life of options outstanding as of December 31, 2018 and 2017 was as follows: 12/31/2018 12/31/2017 Exercisable Stock Stock Weighted Exercisable Stock Stock Weighted $ 0.40 25,000 25,000 0.16 $ 0.09 2,450,000 2,450,000 3.23 $ 0.09 2,450,000 2,450,000 4.23 $ 0.26 13,500,000 13,500,000 3.37 $ 0.26 13,500,000 13,500,000 4.67 15,950,000 15,950,000 15,975,000 15,975,000 The stock-based compensation expense recognized in the statement of operations during the years ended December 31, 2018 and 2017, related to the granting of these options was $0 and $1,265,236, respectively. As of December 31, 2018, and 2017, respectively, there was no intrinsic value with regards to the outstanding options.

Convertible Promissory Notes

Convertible Promissory Notes	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
CONVERTIBLE PROMISSORY NOTES	5. CONVERTIBLE PROMISSORY NOTES As of December 31, 2018 and 2017, the outstanding convertible promissory notes net of debt discount are summarized as follows: 2018 2017 Convertible Promissory Notes, net of debt discount $ 2,470,810 $ 2,187,939 Less current portion 485,837 396,660 Total long-term liabilities $ 1,984,973 $ 1,791,279 Maturities of long-term debt for the next five years are as follows: December 31, Amount 2019 $ 485,837 2020 730,000 2021 685,000 2022 472,000 2023 97,973 $ 2,470,810 At December 31, 2018, the $2,736,710 in convertible promissory notes had a remaining debt discount of $265,900, leaving a net balance of $2,470,810. The Company issued an unsecured convertible promissory note (the May 2014 Note"), in the amount of $500,000 on May 2, 2014. The May Note matures September 18, 2019. The May 2014 Note bears interest at 10% per annum. The May 2014 Note is convertible into shares of the Company's common stock at a conversion price of a) the lesser of $0.25 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the average three (3) lowest trading prices of three (3) separate trading days recorded after the effective date, or c) the lowest effective price granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance with the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The fair value of the May 2014 Note has been determined by using the Binomial lattice formula from the effective date of each tranche. During the year ended the Company issued 19,154,257 shares of common stock upon conversion of principal in the amount of $99,470, plus accrued interest of $36,153, with a fair value loss on conversion of debt in the amount of $385,531. As of December 31, 2018, the remaining balance of the May 2014 Note was $207,160. The Company issued various unsecured convertible promissory notes (the 2015-2018 Notes") in the aggregate amount of $2,500,000 on various dates of January 30, 2015 through February 26, 2018. The 2015-2018 Notes matures on dates from January 30, 2020 thru February 26, 2023. The 2015-2018 Notes bears interest at 10% per annum. The 2015-2018 Notes are convertible into shares of the Company's common stock at conversion prices ranging from the a) the lesser of $0.03 to $0.25 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the lowest trade price recorded since the original effective date, or c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance within the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The fair value of the 2015-2018 Notes have been determined by using the Binomial lattice formula from the effective date of each tranche. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $82,137 during the year ended December 31, 2018. As of December 31, 2018, the remaining aggregate balances of the 2015-2018 Notes were $2,315,000. The Company issued various unsecured convertible promissory notes (the "Jul-Dec 2018 Notes") in the aggregate principal amount of 222,000 on various dates of July 23, 2018 through December 4, 2018. The July-Dec 2018 Notes matures on dates from July 23, 2019 thru December 4, 2019. The Jul-Dec 2018 Notes bears interest at 10% per annum. The Jul-Dec 2018 Notes may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) trading prices during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Jul-Dec 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jul-Dec 2018 Notes. The fair value of the Jul-Dec 2018 Notes has been determined by using the Binomial lattice formula from the effective date of each note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $60,460 during the year ended December 31, 2018. As of December 31, 2018, the remaining aggregate balances of the Jul-Dec 2018 Notes were $222,000. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory note was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The notes have no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically per the stock price fluctuations.

Derivative Liabilities

Derivative Liabilities	12 Months Ended
	Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE LIABILITIES	6. DERIVATIVE LIABILITIES We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory note was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically per the stock price fluctuations. The convertible notes issued and described in Note 5 do not have fixed settlement provisions because their conversion prices are not fixed. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. During the year ended December 31, 2018, as a result of the convertible notes (“Notes”) issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $402,807, based upon a Binomial-Model calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes. During the year ended December 31, 2018, the Company converted $99,470 in principal of convertible notes, plus accrued interest of $36,153. As a result of the conversion of these notes the Company recorded a fair value loss on the conversion of debt in the amount of $385,531 in the statement of operations for the year ended December 31, 2018. At December 31, 2018, the fair value of the derivative liability was $14,009,084. For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation model for the derivative are as follows: 12/31/2018 Risk free interest rate 2.46% - 2.63 % Stock volatility factor 89.0% - 202.0 % Weighted average expected option life 1 years - 5 years Expected dividend yield None

Deferred Taxes

Deferred Taxes	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
DEFERRED TAXES	7. DEFERRED TAXES The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2016. Deferred income taxes have been provided by temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. To the extent allowed by GAAP, we provide valuation allowances against the deferred tax assets for amount when the realization is uncertain. Included in the balance at December 31, 2018 and 2017 are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility. Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period. The Company's policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periods ended December 31, 2018 and 2017, the Company did not recognize interest or penalties. At December 31, 2018, the Company had net operating loss carry-forwards of approximately $8,627,000, which expires 20 years after the NOL year. No tax benefit has been reported in the December 31, 2018 and 2017 financial statements, since the potential tax benefit is offset by a valuation allowance of the same amount. The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2018 and 2017 due to the following: 2018 2017 Book Income (Loss) (2,072,035 ) (1,114,010 ) Depreciation 125 680 Meals and entertainment (1,060 ) 240 Non-deductible non-cash charges 1,924,670 879,830 Valuation Allowance 148,300 233,260 Income tax expense $ - $ - Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Net deferred tax assets consist of the following components as of December 31, 2018 and 2017: 2018 2017 Deferred tax assets: NOL carryover (1,811,705 ) (3,170,060 ) R & D credit 124,840 91,630 Depreciation 10,735 10,740 Deferred tax liabilities: - Less Valuation Allowance 1,676,130 3,067,690 Net deferred tax asset $ - $ - Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cut and Jobs Act (the "Tax Act"). The Tax Act establishes new tax laws that affects 2018 and future years, including a reduction in the U.S. federal corporate income tax rate to 21%, effective January 1, 2018. The Company's tax returns for the previous three years remain open for audit by the respective tax jurisdictions.

Commitment and contingencies

Commitment and contingencies	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
COMMITMENT AND CONTINGENCIES	7. COMMITMENT AND CONTINGENCIES On October 3, 2018, the Company amended its lease for office space by extending the lease to October 31, 2019.

Subsequent Event

Subsequent Event	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENT	8. SUBSEQUENT EVENT Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: On January 17, 2019, the Company received an additional tranche of $25,000 pursuant to the 2015-2018 convertible promissory notes. On January 23, 2019, the Company entered into a convertible promissory note with an investor, providing for the sale by the Company of a 10% unsecured convertible note in the principal amount of $53,000. The Note matures on January 23, 2019. The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of 61% of the average lowest two (2) trading prices for common stock during the fifteen (15) trading day period prior to the conversion date. On January 28, 2019, the Company issued 872,093 shares of common stock upon a partial conversion of the July 2018 convertible promissory note for principal in the sum of $15,000. On January 29, 2019, the Company issued 1,162,791 shares of common stock upon a partial conversion of the July 2018 convertible promissory note for principal in the sum of $20,000. On January 30, 2019, the Company issued 1,590,086 shares of common stock upon a partial conversion of the May 2014 convertible promissory note for principal in the amount of $5,920, plus accrued interest of $2,587. On February 1, 2019, the Company issued 1,175,088 shares of common stock upon a partial conversion of the July 2018 convertible promissory note for principal in the sum of $20,000. On February 5, 2019, the Company issued 671,687 shares of common stock upon a partial conversion of the July 2018 convertible promissory notes for principal in the amount of $8,000, plus accrued interest of $3,150. On February 18, 2019, the Company entered into an agreement with a consultant, who will provide technical consulting services of various research expertise and strategic planning. The agreed upon monthly fee is $6,000 per month for February and March 2019. On February 22, 2019, the Company issued 2,900,064 shares of common stock upon a partial conversion of the May 2014 convertible promissory note for principal in the amount of $10,750, plus accrued interest of $4,765. On February 22, 2020, the Company entered into a secured convertible promissory note with an investor, providing for the sale by the Company of a 10% unsecured convertible note in the principal amount of $53,500 for a purchase price of $51,500, and an original issue discount of $2,000. The Note matures on February 22, 2021. The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of 61% of the average lowest one (1) trading prices for common stock during the fifteen (15) trading day period prior to the conversion date. On February 25, 2019, the Company entered into a secured convertible promissory note with an investor, providing for the sale by the Company of a 10% unsecured convertible note in the principal amount of $53,000. The Note matures on February 25, 2020. The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of 61% of the average lowest one (2) trading prices for common stock during the fifteen (15) trading day period prior to the conversion date On March 7, 2019, the Company issued 1,224,490 shares of common stock upon a partial conversion of the September 2018 convertible promissory note for principal in the amount of $18,000. On March 11, 2019, the Company issued 1,379,310 shares of common stock upon a partial conversion of the September 2018 convertible promissory note for principal in the amount of $20,000. On March 18, 2019, the Company issued 1,288,321 shares of common stock upon a partial conversion of the September 2018 convertible promissory note for principal in the amount of $15,000 and interest in the amount of $2,650.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Revenue Recognition	Revenue Recognition The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, the Company has not had significant revenues and is in the development stage.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Use of Estimates	Use of Estimates In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.
Intangible Assets	Intangible Assets The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. During the years ended December 31, 2018 and 2017 the Company reviewed the capitalized patents for impairment in accordance with ASC 350, and determined there was no impairment. Intangible assets that have finite useful lives continue to be amortized over their useful lives Useful Lives 2018 2017 Patents $ 75,487 $ 75,487 Write-off of abandoned patents (30,151 ) - Less accumulated amortization 15 years (9,067 ) (6,045 ) $ 36,269 $ 69,442 The Company recognized amortization expense of $3,022 and $6,045 for the years ended December 31, 2018 and 2017.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives: Computer equipment 5 Years Machinery and equipment 10 Years Depreciation expense for the years ended December 31, 2018 and 2017 was $3,080 and $3,323, respectively.
Stock-Based Compensation	Stock-Based Compensation The Company measures the cost of employee services received in exchange for an equity award based on the grant-date fair value of the award. All grants under our stock-based compensation programs are accounted for at fair value and that cost is recognized over the period during which an employee, consultant, or director are required to provide service in exchange for the award (the vesting period). Compensation expense for options granted to employees and non-employees is determined in accordance with the standard as the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measured. Compensation expense for awards granted is re-measured each period. Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility. The Company used Black Scholes to value its stock option awards which incorporated the Company's stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life. The stock options terminate seven (7) years from the date of grant or upon termination of employment. As of December 31, 2018, 15,950,000 stock options are outstanding.
Income Taxes	Income Taxes Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. On December 22, 2017, the Tax Cut and Jobs Act (the "Tax Act") was signed into law by the President of the United States. The TCJA is a tax reform act that among other things, reduced corporate income tax rate to 21%, effective January 1, 2018. Accordingly, t
Research and Development	Research and Development Research and development costs are expensed as incurred. Total research and development costs were $239,607 and $176,306 for the years ended December 31, 2018 and 2017, respectively.
Net Earnings (Loss) per Share Calculations	Net Earnings (Loss) per Share Calculations Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock based awards (Note 4), plus the assumed conversion of convertible debt (Note 5).     For the year ended December 31, 2018, the Company's diluted loss per share is the same as the basic loss per share, and the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company has excluded 15,950,000 stock options and the shares issuable from convertible debt of $2,744,160, because their impact was anti-dilutive. For the year ended December 31, 2017, the Company's diluted loss per share is the same as the basic loss per share, and the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company excluded 15,975,000 stock options, and the shares issuable from the convertible debt of $2,193,630, because their impact was antidilutive.  For the Years Ended December 31, 2018 2017 Income (Loss) to common shareholders (Numerator) $ (9,866,829 ) $ (2,785,024 ) Basic weighted average number of common shares outstanding (Denominator) 53,667,779 35,784,211 Diluted weighted average number of common shares outstanding (Denominator) 53,667,779 35,784,211
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2018 and 2017, the amounts reported for cash, inventory, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: · Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; · Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and · Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2018 and 2017: Total (Level 1) (Level 2) (Level 3) Derivative Liability Total Liabilities measured at fair value as of December 31, 2018 $ 14,032,942 $ - $ - $ 14,032,942 Total Liabilities measured at fair value as of December 31, 2017 $ 5,239,073 $ - $ - $ 5,239,073 Fair Value of Financial Instruments The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: Balance as of December 31, 2016 $ 5,044,897 Fair value of derivative liabilities issued 15,840 Gain on change in derivative liability 178,336 Balance as of December 31, 2017 $ 5,239,073 Fair value of derivative liabilities issued 402,808 Loss on change in derivative liability 8,391,061 Balance as of December 31, 2018 $ 14,032,942
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In August 2017, FASB issued accounting standards update ASU-2017-12, "D" (Topic 815) – "Targeted Improvements to Accounting for Hedging Activities", to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company is currently evaluating the impact of the adoption of ASU 2017-12 on the Company's financial statements. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – "Shared-Based Payment Arrangements with Nonemployees", which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company is currently evaluating the impact of the adoption of ASU 2018-07 on the Company's financial statements. In August 2018, the FASB issued to accounting standards update ASU 2018-13, (Topic 820) - "Fair Value Measurement", which changes the unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance. The Company is currently evaluation the impact of the adoption of ASU 2018-13, on the Company's financial statements. Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.
Reclassification	Reclassification Certain amounts in the 2017 financial statements have been reclassified to conform to the presentation used in the 2018 financial statements. There was no material impact on any of the Company's previously issued financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Schedule of intangible assets amortized over their useful lives	Useful Lives 2018 2017 Patents $ 75,487 $ 75,487 Write-off of abandoned patents (30,151 ) - Less accumulated amortization 15 years (9,067 ) (6,045 ) $ 36,269 $ 69,442
Schedule of property and equipment	Computer equipment 5 Years Machinery and equipment 10 Years
Schedule of net earnings per share	For the Years Ended December 31, 2018 2017 Income (Loss) to common shareholders (Numerator) $ (9,866,829 ) $ (2,785,024 ) Basic weighted average number of common shares outstanding (Denominator) 53,667,779 35,784,211 Diluted weighted average number of common shares outstanding (Denominator) 53,667,779 35,784,211
Schedule of assets and liabilities measured at fair value on recurring basis	Total (Level 1) (Level 2) (Level 3) Derivative Liability Total Liabilities measured at fair value as of December 31, 2018 $ 14,032,942 $ - $ - $ 14,032,942 Total Liabilities measured at fair value as of December 31, 2017 $ 5,239,073 $ - $ - $ 5,239,073
Schedule of reconciliation of derivative liability	Balance as of December 31, 2016 $ 5,044,897 Fair value of derivative liabilities issued 15,840 Gain on change in derivative liability 178,336 Balance as of December 31, 2017 $ 5,239,073 Fair value of derivative liabilities issued 402,808 Loss on change in derivative liability 8,391,061 Balance as of December 31, 2018 $ 14,032,942

Stock Options (Tables)

Stock Options (Tables)	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of stock options	12/31/2018 12/31/2017 Number of Weighted Number of Weighted Outstanding as of the beginning of the years 15,975,000 $ 0.23 15,975,000 $ 0.23 Granted - - - - Exercised - - - - Expired (25,000 ) $ 0.40 - - Outstanding as of the end of the years 15,950,000 $ 0.23 15,975,000 $ 0.23 Exercisable as of the end of the years 15,950,000 $ 0.23 15,435,000 $ 0.23
Schedule of weighted average remaining contractual life of options outstanding	12/31/2018 12/31/2017 Exercisable Stock Stock Weighted Exercisable Stock Stock Weighted $ 0.40 25,000 25,000 0.16 $ 0.09 2,450,000 2,450,000 3.23 $ 0.09 2,450,000 2,450,000 4.23 $ 0.26 13,500,000 13,500,000 3.37 $ 0.26 13,500,000 13,500,000 4.67 15,950,000 15,950,000 15,975,000 15,975,000

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Schedule of outstanding convertible promissory notes	2018 2017 Convertible Promissory Notes, net of debt discount $ 2,470,810 $ 2,187,939 Less current portion 485,837 396,660 Total long-term liabilities $ 1,984,973 $ 1,791,279
Schedule of maturities of long-term debt	December 31, Amount 2019 $ 485,837 2020 730,000 2021 685,000 2022 472,000 2023 97,973 $ 2,470,810

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	12 Months Ended
	Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of derivative liabilities valuation assumptions	12/31/2018 Risk free interest rate 2.46% - 2.63 % Stock volatility factor 89.0% - 202.0 % Weighted average expected option life 1 years - 5 years Expected dividend yield None

Deferred Taxes (Tables)

Deferred Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Schedule of components of income tax expense	2018 2017 Book Income (Loss) (2,072,035 ) (1,114,010 ) Depreciation 125 680 Meals and entertainment (1,060 ) 240 Non-deductible non-cash charges 1,924,670 879,830 Valuation Allowance 148,300 233,260 Income tax expense $ - $ -
Schedule of deferred tax assets and liabilities	2018 2017 Deferred tax assets: NOL carryover (1,811,705 ) (3,170,060 ) R & D credit 124,840 91,630 Depreciation 10,735 10,740 Deferred tax liabilities: - Less Valuation Allowance 1,676,130 3,067,690 Net deferred tax asset $ - $ -

Organization and Line of Busi_2

Organization and Line of Business (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Organization and Line of Business (Textual)
Net loss	$ (9,866,829)	$ (2,785,024)
Used cash in operations	(630,979)	(560,483)
Working capital deficiency	15,062,687
Shareholders' deficit	$ (17,000,210)	$ (7,654,535)	$ (6,644,200)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Patents	$ 75,487	$ 75,487
Write-off of abandoned patents	(30,151)
Less accumulated amortization	(9,067)	(6,045)
Patents, net	$ 36,269	$ 69,442
Patents, Useful Lives	15 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 1)	12 Months Ended
	Dec. 31, 2018
Computer equipment [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Property and equipment, Useful lives	5 years
Machinery and equipment [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Property and equipment, Useful lives	10 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details 2) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Income (Loss) to common shareholders (Numerator)	$ (9,866,829)	$ (2,785,024)
Basic weighted average number of common shares outstanding (Denominator)	53,667,779	35,784,211
Diluted weighted average number of common shares outstanding (Denominator)	53,667,779	35,784,211

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details 3) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Derivative Liability
Total Liabilities measured at fair value	$ 14,032,942	$ 5,239,073
Fair Value, Inputs, Level 1 [Member]
Derivative Liability
Total Liabilities measured at fair value
Fair Value, Inputs, Level 2 [Member]
Derivative Liability
Total Liabilities measured at fair value
Fair Value, Inputs, Level 3 [Member]
Derivative Liability
Total Liabilities measured at fair value	$ 14,032,942	$ 5,239,073

Summary of Significant Accoun_8

Summary of Significant Accounting Policies (Details 4) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Schedule of reconciliation of derivative liability
Balance as of December 31, 2017	$ 5,239,073	$ 5,044,897
Fair value of derivative liabilities issued	402,808	15,840
Gain (loss) on change in derivative liability	8,391,061	178,336
Balance as of December 31, 2018	$ 14,032,942	$ 5,239,073

Summary of Significant Accoun_9

Summary of Significant Accounting Policies (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 22, 2018	Dec. 31, 2018	Dec. 31, 2017
Summary of Significant Accounting Policies (Textual)
Depreciation expense		$ 3,080	$ 3,323
Tax settlement, percentage		Tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority
Corporate income tax rate	21.00%	21.00%
Research and development costs		$ 239,607	176,306
Amortization expense		$ 3,022	$ 6,045
Stock options [Member]
Summary of Significant Accounting Policies (Textual)
Expiration period		7 years
Antidilutive securities excluded from computation of earnings per share, amount		15,950,000	15,975,000
Outstanding stock options		15,950,000
Convertible debt [Member]
Summary of Significant Accounting Policies (Textual)
Antidilutive securities excluded from computation of earnings per share, amount		2,744,160	2,193,630

Capital Stock (Details)

Capital Stock (Details) - Convertible promissory notes [Member] - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Capital Stock (Textual)
Common stock issued	19,154,257	11,965,646
Aggregate fair value loss	$ 385,531	$ 408,144
Amount of debt conversion	99,470	78,370
Accrued interest	$ 36,153	$ 22,939
Maximum [Member]
Capital Stock (Textual)
Common stock conversion price per share	$ 0.048	$ 0.0549
Minimum [Member]
Capital Stock (Textual)
Common stock conversion price per share	$ 0.0157	$ 0.0350

Stock Options (Details)

Stock Options (Details) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Number of Options
Outstanding as of the beginning of the years	15,975,000	15,975,000
Granted
Exercised
Expired	(25,000)
Outstanding as of the end of the years	15,950,000	15,975,000
Exercisable as of the end of the years	15,950,000	15,435,000
Weighted average exercise price
Outstanding as of the beginning of the years	$ 0.23	$ 0.23
Granted
Exercised
Expired	0.40
Outstanding as of the end of the years	0.23	0.23
Exercisable as of the end of the years	$ 0.23	$ 0.23

Stock Options (Details 1)

Stock Options (Details 1) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Schedule of weighted average remaining contractual life of options outstanding
Stock Options Outstanding	15,950,000	15,975,000
Stock Options Exercisable	15,950,000	15,975,000
Exercisable Price One [Member]
Schedule of weighted average remaining contractual life of options outstanding
Exercisable Price	$ 0.09	$ 0.09
Stock Options Outstanding	2,450,000	2,450,000
Stock Options Exercisable	2,450,000	2,450,000
Weighted Average Remaining Contractual Life (years)	3 years 2 months 23 days	4 years 2 months 23 days
Exercisable Price Two [Member]
Schedule of weighted average remaining contractual life of options outstanding
Exercisable Price	$ 0.26	$ 0.26
Stock Options Outstanding	13,500,000	13,500,000
Stock Options Exercisable	13,500,000	13,500,000
Weighted Average Remaining Contractual Life (years)	3 years 4 months 13 days	4 years 8 months 2 days
Exercisable Price [Member]
Schedule of weighted average remaining contractual life of options outstanding
Exercisable Price		$ 0.40
Stock Options Outstanding		25,000
Stock Options Exercisable		25,000
Weighted Average Remaining Contractual Life (years)		1 month 27 days

Stock Options (Details Textual)

Stock Options (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Stock Options (Textual)
Stock-based compensation expense		$ 1,265,236
Stock Options [Member]
Stock Options (Textual)
Stock-based compensation expense	0	1,265,236
Intrinsic value of options outstanding

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Debt Disclosure [Abstract]
Convertible Promissory Notes, net of debt discount	$ 2,470,810	$ 2,187,939
Less current portion	485,837	396,660
Total long-term liabilities	$ 1,984,973	$ 1,791,279

Convertible Promissory Notes _2

Convertible Promissory Notes (Details 1) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Year Ending December 31,
2019	$ 485,837
2020	730,000
2021	685,000
2022	472,000
2023	97,973
Total long-term debt	$ 1,984,973	$ 1,791,279

Convertible Promissory Notes _3

Convertible Promissory Notes (Details Textual) - USD ($)	May 02, 2014	Feb. 26, 2018	Dec. 04, 2018	Dec. 31, 2018	Dec. 31, 2017
Convertible Promissory Notes (Textual)
Convertible promissory notes				$ 2,736,710
Debt discount				265,900
Net balance				2,470,810	$ 2,187,939
Loss on conversion of debt				$ (385,531)	$ (408,144)
May 2014 Note [Member]
Convertible Promissory Notes (Textual)
Unsecured convertible promissory note	$ 500,000
Note maturity date	Sep. 18, 2019
Note bears interest rate	10.00%
Debt conversion, description	Note is convertible into shares of the Company’s common stock at a conversion price of a) the lesser of $0.25 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the average three (3) lowest trading prices of three (3) separate trading days recorded after the effective date, or c) the lowest effective price granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance with the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered.
Shares of common stock upon conversion				19,154,257
Shares of common stock upon conversion of principal amount				$ 99,470
Accrued interest				36,153
Loss on conversion of debt				385,531
Remaining balance of note				207,160
2015-2018 Notes [Member]
Convertible Promissory Notes (Textual)
Debt discount				82,137
Unsecured convertible promissory note		$ 2,500,000
Note bears interest rate		10.00%
Debt conversion, description		The 2015-2018 Notes are convertible into shares of the Company’s common stock at conversion prices ranging from the a) the lesser of $0.03 to $0.25 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the lowest trade price recorded since the original effective date, or c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance within the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered.
Remaining balance of note				2,315,000
Note maturity date, description		The 2015-2018 Notes matures on dates from January 30, 2020 thru February 26, 2023.
Jul-Dec 2018 Notes [Member]
Convertible Promissory Notes (Textual)
Debt discount				60,460
Unsecured convertible promissory note			$ 222,000
Note bears interest rate			10.00%
Debt conversion, description			The Jul-Dec 2018 Notes may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) trading prices during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Jul-Dec 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jul-Dec 2018 Notes.
Remaining balance of note				$ 222,000
Note maturity date, description			The July-Dec 2018 Notes matures on dates from July 23, 2019 thru December 4, 2019.

Derivative Liabilities (Details

Derivative Liabilities (Details)	12 Months Ended
	Dec. 31, 2018
Expected dividend yield
Minimum [Member]
Risk free interest rate	2.46%
Stock volatility factor	89.00%
Weighted average expected option life	1 year
Maximum [Member]
Risk free interest rate	2.63%
Stock volatility factor	202.00%
Weighted average expected option life	5 years

Derivative Liabilities (Detai_2

Derivative Liabilities (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Derivative Liabilities (Textual)
Fair value loss on the conversion of debt	$ (385,531)	$ (408,144)
Fair value of the derivative liability	14,032,942	$ 5,239,073	$ 5,044,897
Convertible Notes [Member]
Derivative Liabilities (Textual)
Fair value of the conversion feature	402,807
Amount of debt conversion	99,470
Fair value loss on the conversion of debt	385,531
Accrued interest	$ 36,153

Deferred Taxes (Details)

Deferred Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Book Income (Loss)	$ (2,072,035)	$ (1,114,010)
Depreciation	125	680
Meals and entertainment	(1,060)	240
Non-deductible non-cash charges	1,924,670	879,830
Valuation Allowance	148,300	233,260
Income tax expense

Deferred Taxes (Details 1)

Deferred Taxes (Details 1) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Deferred tax assets:
NOL carryover	$ (1,811,705)	$ (3,170,060)
R & D credit	124,840	91,630
Depreciation	10,735	10,740
Deferred tax liabilities:
Depreciation
Less Valuation Allowance	1,676,130	3,067,690
Net deferred tax asset

Deferred Taxes (Details Textual

Deferred Taxes (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 22, 2017	Dec. 31, 2018	Dec. 31, 2017
Deferred Taxes (Textual)
Operating loss carry-forwards		$ 8,627,000
Operating loss carry-forwards expiration, term		Which expires 20 years after the NOL year.
U.S. federal corporate income tax rate	21.00%
Deferred tax assets and liabilities provisional decrease			$ 1,506,651
Net adjustment to the valuation allowance			$ 1,506,651

Subsequent Event (Details)

Subsequent Event (Details) - USD ($)

Mar. 11, 2019

Mar. 07, 2019

Feb. 22, 2020

Mar. 18, 2019

Feb. 25, 2019

Feb. 22, 2019

Feb. 05, 2019

Feb. 01, 2019

Jan. 30, 2019

Jan. 29, 2019

Jan. 28, 2019

Jan. 23, 2019

Jan. 17, 2019

Dec. 31, 2018

Dec. 31, 2017

Mar. 31, 2019

Feb. 28, 2019

Subsequent Event (Textual)

Additional tranches amount received

$ 600,000

$ 472,000

2015-2018 Convertible Promissory Notes [Member] | Subsequent Event [Member]

Subsequent Event (Textual)

Additional tranches amount received

$ 25,000

Convertible Note [Member] | Subsequent Event [Member]

Subsequent Event (Textual)

Principal amount

$ 53,000

Unsecured convertible note, percentage

10.00%

Convertible note, maturity date

Jan. 23, 2019

Conversion of common stock, description

The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of 61% of the average lowest two (2) trading prices for common stock during the fifteen (15) trading day period prior to the conversion date.

July 2018 Convertible Promissory Notes [Member] | Subsequent Event [Member]

Subsequent Event (Textual)

Common stock upon conversion issued, shares

671,687

1,175,088

1,162,791

872,093

Common stock upon conversion issued, amount

$ 8,000

$ 20,000

$ 20,000

$ 15,000

Accrued interest

$ 3,150

May 2014 Convertible Promissory Note [Member] | Subsequent Event [Member]

Subsequent Event (Textual)

Common stock upon conversion issued, shares

2,900,064

1,590,086

Common stock upon conversion issued, amount

$ 10,750

$ 5,920

Accrued interest

$ 4,765

$ 2,587

Consultant [Member] | Subsequent Event [Member]

Subsequent Event (Textual)

Monthly fee

$ 6,000

$ 6,000

Secured Convertible Promissory Note [Member] | Subsequent Event [Member]

Subsequent Event (Textual)

Principal amount

$ 53,500

Unsecured convertible note, percentage

10.00%

Convertible note, maturity date

Feb. 25, 2020

Conversion of common stock, description

The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of 61% of the average lowest one (2) trading prices for common stock during the fifteen (15) trading day period prior to the conversion date

Secured Convertible Promissory Note [Member] | Subsequent Event [Member] | Forecast [Member]

Subsequent Event (Textual)

Principal amount

$ 53,500

Unsecured convertible note, percentage

10.00%

Convertible note, maturity date

Feb. 22, 2021

Conversion of common stock, description

The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of 61% of the average lowest one (1) trading prices for common stock during the fifteen (15) trading day period prior to the conversion date.

Original issue discount

$ 2,000

Purchase price

$ 51,500

September 2018 Convertible Promissory Note | Subsequent Event [Member]

Subsequent Event (Textual)

Common stock upon conversion issued, shares

1,379,310

1,224,490

1,288,321

Common stock upon conversion issued, amount

$ 20,000

$ 18,000

$ 15,000

Accrued interest

$ 2,650